Compared to Semaglutide and Tirzepatide, retatrutide's special inclusion of glucagon receptor agonism together with GIP and GLP-1 receptor agonism offers a definite pharmacological profile. While Semaglutide is actually a GLP-1 receptor agonist and Tirzepatide brings together GLP-one and GIP receptor agonism, retatrutide's triple mechanism could likely give broader metabolic benefits. https://corepepptides.com/product/retatrutide-injection-pen/